2 Safety and early evidence of activity of a first-in-human...

European Journal of Cancer 2014 / 11 Vol. 50

2 Safety and early evidence of activity of a first-in-human phase I study of the novel cancer stem cell (CSC) targeting antibody OMP-52M51 (anti-Notch1) administered intravenously to patients with certain advanced solid tumors

Patnaik, A., LoRusso, P., Munster, P., Tolcher, A.W., Davis, S.L., Heymach, J., Ferraroto, R., Xu, L., Kapoun, A.M., Faoro, L., Lewicki, J.A., Dupont, J., Eckhardt, S.G.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
50
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(14)70128-5
Date:
November, 2014
File:
PDF, 54 KB
english, 2014
Conversion to is in progress
Conversion to is failed